More than ever, hospital executives are called to recognize risks and opportunities associated with sterile compounding and take action to achieve compliance to optimize patient safety guidance…

“Sterile compounding practices are increasingly under scrutiny. State pharmacy boards, in tandem with national efforts by accreditation organizations, are raising the stakes on this critical component of care delivery…”

Read full article, The Bottom Line on USP Compliance: What is Your Risk? by Becker’s Hospital Review.

Evaluating a new 503B partner, or just auditing your current partner?

Download this valuable checklist to help you assess their quality and compliance.